Study of the Safety and Efficacy of LY3016859 after Multiple Dosing in Diabetic Patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-004496-40

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To investigate the safety and tolerability of multiple IV doses of LY3016859 in DN patients To evaluate the effect of multiple IV dosing of LY3016859 on change from baseline in proteinuria at 16 weeks in DN patients (Part B only)


Critère d'inclusion

  • Chronic kidney disease associated with Diabetic nephropathy